WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

WMT

82.45

+0.4%↑

165.27

+0.17%↑

COST

885.66

+0.97%↑

+0.12%↑

PEP

166.25

+0.43%↑

Accueil・Liste d'Actions・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Ouvert

Secteur Consommation de base

5.99 2.74

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

5.64

Max

6.05

Chiffres clés
By Trading Economics
Revenu	-7.1M
Ventes	38M
BPA	-0.232
Marge bénéficiaire	-18.686

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+10.54 upside

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-5.2M 188M
Ouverture précédente	3.25
Clôture précédente	5.99

Sentiment de l'Actualité

By Acuity

28%

72%

39 / 151 Classement par Consumer defensive

Lifecore Biomedical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 nov. 2024, 23:05 UTC

Actualités

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3 nov. 2024, 21:12 UTC

Résultats

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3 nov. 2024, 20:59 UTC

Résultats

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3 nov. 2024, 23:34 UTC

Actualités

Stocks Poised for Lower Open -- Barrons.com

3 nov. 2024, 23:16 UTC

Actualités

Résultats

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3 nov. 2024, 22:50 UTC

Acquisitions, Fusions, Rachats

Santos Says Working Interest in PNG LNG Now 39.9%

3 nov. 2024, 22:50 UTC

Acquisitions, Fusions, Rachats

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3 nov. 2024, 22:49 UTC

Acquisitions, Fusions, Rachats

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3 nov. 2024, 22:49 UTC

Acquisitions, Fusions, Rachats

Santos Receives Final $241 Million Payment From Kumul

3 nov. 2024, 22:48 UTC

Acquisitions, Fusions, Rachats

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3 nov. 2024, 20:37 UTC

Résultats

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3 nov. 2024, 20:36 UTC

Résultats

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3 nov. 2024, 20:35 UTC

Résultats

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3 nov. 2024, 20:35 UTC

Résultats

Westpac Raises Share Buyback Program by A$1 Billion

3 nov. 2024, 20:35 UTC

Résultats

Westpac Final Dividend A$0.76/Share

3 nov. 2024, 20:33 UTC

Résultats

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3 nov. 2024, 20:32 UTC

Résultats

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3 nov. 2024, 20:32 UTC

Résultats

Westpac FY Net Profit A$6.99 Billion, Down 3%

3 nov. 2024, 18:09 UTC

Actualités

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3 nov. 2024, 10:30 UTC

Actualités

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3 nov. 2024, 03:00 UTC

Actualités

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2 nov. 2024, 13:53 UTC

Actualités

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 nov. 2024, 13:44 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 13:00 UTC

Actualités

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 nov. 2024, 12:58 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 12:48 UTC

Actualités

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 nov. 2024, 12:32 UTC

Résultats

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Comparaison

Variation de prix

Lifecore Biomedical Inc prévision

Objectif de Prix

By TipRanks

10.54% hausse

Prévisions sur 12 Mois

Moyen 6.5 USD 10.54%

Haut 8 USD

Bas 5 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

Achat

Maintien

Vente

Basé sur 3 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

39 / 151Classement par Consommation de base

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Lifecore Biomedical Inc

Landec Corporation designs, develops, manufactures, and sells differentiated products for food and biomaterials markets. The Company licenses technology applications to partners. Its two operating businesses include Curation Foods, Inc. (Curation Foods) and Lifecore Biomedical, Inc. (Lifecore). Curation Foods is engaged in processing, marketing, and selling of fresh packaged plant-based salads and vegetables. Curation Foods brands include Eat Smart, O Olive Oil & Vinegar, Yucatan & Cabo Fresh Avocado Product, BreatheWay Packaging Technology and Windset. Lifecore is an integrated contract development and manufacturing organization (CDMO) that offers sterile, injectable pharmaceutical products in syringes and vials. Lifecore also manufactures pharmaceutical-grade sodium hyaluronate (HA). Its services include technology development, material component changes, analytical method development and formulation development.